NFKB1 and ulcerative colitis: PCSE with rich phenolics may inhibit NF-κB pathway or block the entry of NF-κB into the nucleus, rendering it unable to activate cytokines, and thus PCSE acts as a potential anti-ulcerative colitis drug.